QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo 期刊论文 MOLECULAR MEDICINE REPORTS, 2018, 卷号: 17, 期号: 4 作者:  Jia, Xiaoqing;  Cheng, Jingyi;  Shen, Zhenzhou;  Shao, Zhimin;  Liu, Guangyu 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 zoledronic acid  hypoxia-inducible factor-1  fulvestrant  breast cancer   Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer 期刊论文 EUROPEAN JOURNAL OF CANCER, 2018, 卷号: 94 作者:  Robertson, John F. R.;  Cheung, Kwok-Leung;  Noguchi, Shinzaburo;  Shao, Zhimin;  Degboe, Arnold 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Anastrozole  FALCON  Fulvestrant  Health-related quality of life  Locally advanced or metastatic breast cancer   Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON) 期刊论文 BREAST CANCER, 2018, 卷号: 25, 期号: 3 作者:  Noguchi, Shinzaburo;  Ellis, Matthew J.;  Robertson, John F. R.;  Thirlwell, Jackie;  Fazal, Mehdi 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 Asian  Anastrozole  Fulvestrant  Progression-free survival  Safety   The feasibility of F-18-FES and F-18-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ER alpha in ER alpha plus breast cancer 期刊论文 ANNALS OF NUCLEAR MEDICINE, 2018, 卷号: 32, 期号: 4 作者:  Liu, Shuai;  Gu, Bingxin;  Zhang, Jianping;  Zhang, Yongping;  Xu, Xiaoping 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05 F-18-FES  F-18-FDG  Estrogen receptor alpha  Fulvestrant  Docetaxel insensitivity   Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2-Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study 期刊论文 SCIENTIFIC REPORTS, 2018, 卷号: 8 作者:  Zhao, Yannan;  Liu, Cheng;  Zhang, Yingjian;  Gong, Chengcheng;  Li, Yi 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells 期刊论文 ANTI-CANCER DRUGS, 2018, 卷号: 29, 期号: 6 作者:  Zhou, Qian;  Zeng, Hui;  Ye, Peng;  Shi, Yu;  Guo, Juan 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 breast cancer  fulvestrant  microarray  microRNA  tamoxifen   Comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy: a network meta-analysis 期刊论文 CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10, 页码: 5869-5880 作者:  Zhang, Tingting;  Feng, Fubin;  Zhao, Wenge;  Yao, Yan;  Tian, Jinhui 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 advanced breast cancer  endocrine therapy  targeted therapy  progression-free survival  objective response rate  network  meta-analysis   Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis 期刊论文 2018, 卷号: 171, 期号: 3, 页码: 535-544 作者:  Wang, Jiayu;  Xu, Binghe;  Wang, Wenna;  Zhai, Xiaoyu;  Chen, Xuelian 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 Advanced breast cancer  Hormone receptor  Fulvestrant  Aromatase inhibitors  Postmenopausal